Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.8M Buy
1,065,102
+291,245
+38% +$9.32M 0.01% 688
2026
Q1
$12.7M Buy
773,857
+36,576
+5% +$580K ﹤0.01% 1418
2025
Q4
$11.4M Buy
737,281
+661,454
+872% +$9.59M ﹤0.01% 1477
2025
Q3
$766K Hold
75,827
﹤0.01% 2741
2025
Q2
$723K Buy
75,827
+25,314
+50% +$187K ﹤0.01% 2754
2025
Q1
$349K Hold
50,513
﹤0.01% 3003
2024
Q4
$515K Hold
50,513
﹤0.01% 2977
2024
Q3
$390K Hold
50,513
﹤0.01% 3090
2024
Q2
$379K Buy
+50,513
New +$385K ﹤0.01% 3083
2023
Q2
Sell
-23,997
Closed -$102K 3206
2023
Q1
$102K Hold
23,997
﹤0.01% 3055
2022
Q4
$103K Hold
23,997
﹤0.01% 3107
2022
Q3
$160K Hold
23,997
﹤0.01% 3130
2022
Q2
$167K Buy
+23,997
New +$246K ﹤0.01% 3164

Other funds holding AIP

Nuveen's AIP Position: Q2 2026 in Review

Nuveen increased its Arteris (AIP) stake by 38% in Q2 2026, buying an estimated $9.32M and bringing the position to 1,065,102 shares worth $51.8M. The position accounts for 0.01% of the portfolio, ranked #688.

Nuveen first reported a position in AIP in Q2 2022 and has held it in 13 quarters since. 211 funds tracked by Wall St. Rank hold AIP as of Q2 2026.

  • Nuveen held 1,065,102 shares of Arteris worth $51.8M as of Q2 2026.
  • Nuveen bought 291,245 Arteris shares in Q2 2026, an estimated $9.32M.
  • Arteris made up 0.01% of Nuveen's portfolio in Q2 2026, its #688 holding.
  • Nuveen first reported a position in Arteris in Q2 2022 and has held it in 13 quarters since.
  • 211 funds tracked by Wall St. Rank held Arteris as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.